Profile data is unavailable for this security.
About the company
DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, enterprise-edge information technology (IT) management, health IT systems, performance-based logistics and robotics and unmanned systems.
- Revenue in USD (TTM)401.00m
- Net income in USD2.07m
- Incorporated1969
- Employees3.20k
- LocationDLH Holdings Corp3565 Piedmont RoadNe, Building 3, Suite 700ATLANTA 30305United StatesUSA
- Phone+1 (866) 952-1647
- Websitehttps://www.dlhcorp.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Burning Rock Biotech Ltd (ADR) | 74.25m | -90.31m | 82.14m | 1.14k | -- | 0.7738 | -- | 1.11 | -0.882 | -0.882 | 0.7251 | 1.03 | 0.4091 | 1.75 | 3.57 | -- | -49.76 | -37.09 | -66.95 | -45.29 | 67.59 | 70.02 | -121.63 | -123.88 | 3.09 | -- | -- | -- | -4.58 | 20.81 | 32.69 | -- | -- | -- |
| Oncology Institute Inc | 324.24m | -67.88m | 86.95m | 800.00 | -- | 1.52 | -- | 0.2682 | -0.9187 | -0.9187 | 4.39 | 0.7691 | 1.38 | 23.08 | 7.89 | 405,298.80 | -35.28 | -- | -40.88 | -- | 18.37 | 19.54 | -25.62 | -9.99 | 3.73 | -8.16 | 0.6036 | -- | 28.42 | 23.43 | -99,919.12 | -- | 45.68 | -- |
| ProPhase Labs Inc | 44.38m | -16.78m | 113.14m | 113.00 | -- | 2.29 | -- | 2.55 | -0.9544 | -0.9544 | 2.53 | 2.74 | 0.4943 | 7.20 | 1.21 | 392,778.80 | -18.69 | 0.9106 | -23.53 | 1.12 | 36.59 | 50.32 | -37.81 | 0.9325 | 2.10 | -18.06 | 0.1521 | 665.78 | -63.81 | 27.59 | -190.90 | -- | 86.46 | -- |
| Biodesix Inc | 49.09m | -52.15m | 137.49m | 217.00 | -- | 25.42 | -- | 2.80 | -0.6469 | -0.6469 | 0.5979 | 0.0476 | 0.5113 | -- | 7.70 | 226,207.40 | -54.32 | -55.60 | -76.83 | -80.94 | 73.50 | 59.53 | -106.23 | -105.15 | -- | -4.33 | 0.8851 | -- | 28.46 | 19.16 | 20.32 | -- | 106.31 | -- |
| Longduoduo Co Ltd | 7.27m | 831.39k | 152.73m | -- | 184.09 | -- | 143.67 | 21.02 | 0.0277 | 0.0277 | 0.2421 | -0.0035 | 4.27 | 620.94 | 103.11 | -- | 58.23 | -- | -- | -- | 92.91 | -- | 13.63 | -- | 0.8548 | -- | -- | -- | 17.93 | -- | 99.48 | -- | -- | -- |
| DLH Holdings Corp | 401.00m | 2.07m | 158.25m | 3.20k | 84.92 | 1.50 | 8.12 | 0.3946 | 0.131 | 0.131 | 27.73 | 7.43 | 1.15 | -- | 6.64 | 125,310.90 | 0.5911 | 5.38 | 0.7382 | 7.20 | 20.83 | 20.56 | 0.515 | 3.41 | -- | 1.45 | 0.6158 | 0.00 | -4.88 | 23.05 | -93.73 | -28.16 | -0.903 | -- |
| 23andMe Holding Co. | 247.99m | -521.97m | 172.01m | 769.00 | -- | 0.4557 | -- | 0.6936 | -1.10 | -1.10 | 0.5293 | 0.7817 | 0.3037 | 9.82 | 11.03 | 322,479.80 | -63.93 | -- | -81.01 | -- | 45.30 | -- | -210.48 | -- | 2.04 | -- | 0.00 | -- | 10.15 | -- | -43.30 | -- | -- | -- |
| Joint Corp | 117.70m | -9.75m | 177.61m | 444.00 | -- | 7.17 | -- | 1.51 | -0.6614 | -0.6614 | 7.98 | 1.68 | 1.30 | -- | 30.85 | 265,081.90 | -10.80 | 4.32 | -15.75 | 6.05 | 91.04 | 90.28 | -8.29 | 3.68 | -- | 451.96 | 0.0769 | -- | 16.24 | 26.27 | -1,656.09 | -- | 35.09 | -- |
| American Oncology Network Inc | 1.28bn | -9.12m | 190.37m | 1.53k | -- | -- | -- | 0.1488 | -1.19 | -1.19 | 145.02 | -10.16 | -- | -- | -- | 838,809.80 | -- | -- | -- | -- | 6.47 | -- | -4.92 | -- | 1.38 | -3.52 | 0.5499 | -- | 11.27 | -- | -- | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Wynnefield Capital, Inc.as of 31 Dec 2023 | 3.68m | 25.87% |
| Cove Street Capital LLCas of 18 Jan 2024 | 608.56k | 4.28% |
| Punch & Associates Investment Management, Inc.as of 31 Dec 2023 | 586.10k | 4.12% |
| Wasatch Advisors, Inc.as of 31 Dec 2023 | 548.22k | 3.85% |
| Minerva Advisors LLCas of 31 Dec 2023 | 505.58k | 3.55% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 500.36k | 3.52% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 272.07k | 1.91% |
| Perritt Capital Management, Inc.as of 31 Dec 2023 | 226.24k | 1.59% |
| Dimensional Fund Advisors LPas of 31 Dec 2023 | 186.93k | 1.31% |
| Ancora Advisors LLCas of 31 Dec 2023 | 169.20k | 1.19% |
